• a randomised🔍
• Additional analyses from the phase III RESORCE trial🔍
• Regorafenib — a new RESORCE in HCC🔍
• Sorafenib in Advanced Hepatocellular Carcinoma🔍
• Cabozantinib in Patients with Advanced and Progressing ...🔍
• Tislelizumab vs Sorafenib as First|Line Treatment for Unresectable ...🔍
• The Leaf Clinical Trials Corpus🔍
• a new resource for query generation from clinical trial eligibility criteria🔍

a randomised, double-blind, placebo-controlled, phase 3 trial

... New York, NY, USA; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. 20 Department of Medicine, Division of ...

a randomised, double-blind, placebo-controlled, phase 3 trial

Therefore, new effective systemic therapies for patients with advanced HCC who fail sorafenib treatment are needed. Added value of this study.

a randomised, double-blind, placebo-controlled, phase 3 trial

Author resources · Publishing excellence · Peer review ... Wilhelm, SM ∙ Dumas, J ∙ Adnane, L ∙ et al. Regorafenib (BAY 73-4506): a new ...

Additional analyses from the phase III RESORCE trial - PubMed

Liver Cancer Program, Division of Liver Diseases, Mount Sinai Medical Center, New York, NY, USA. 13 Medical Oncology Division, University of Kansas School of ...

Regorafenib — a new RESORCE in HCC - Nature

On the basis of positive signals from a previous phase II study, Jordi Bruix and colleagues conducted the phase III RESORCE trial, in which 567 ...

RESORCE: An ongoing randomized, double-blind, phase III trial of ...

JCO Resource Centers. Breast CancerNon–Small Cell Lung CancerRenal Cell ... Small Cell Lung Cancer: New Hope, New Challenges. Recommended ...

Sorafenib in Advanced Hepatocellular Carcinoma

No effective systemic therapy exists for patients with advanced hepatocellular carcinoma. A preliminary study suggested that sorafenib, ...

Cabozantinib in Patients with Advanced and Progressing ...

European Association for the Study of the Liver, European Organisation for Research and Treatment Of Cancer. ... create a new password.

Tislelizumab vs Sorafenib as First-Line Treatment for Unresectable ...

... study drug and up to either 30 days following discontinuation of the study drug or the start of new anticancer therapy. Statistical Analysis.

The Leaf Clinical Trials Corpus: a new resource for query generation ...

The LCT corpus is designed as a granular and robust resource of annotated eligibility criteria to enable models for entity and relation ...

a new resource for query generation from clinical trial eligibility criteria

Title:The Leaf Clinical Trials Corpus: a new resource for query generation from clinical trial eligibility criteria ... Abstract:Identifying ...

Updated overall survival (OS) analysis from the international, phase ...

Open table in a new tab. Conclusion: The results of this updated OS analysis with a longer follow-up from the RESORCE trial confirm the results of the ...

Imfinzi plus Imjudo demonstrated unprecedented overall survival in ...

Longest survival follow-up ever reported for a Phase III immunotherapy trial in this setting ... new hope for long-term survivorship to patients ...

A Phase III, Randomized Clinical Trial (LAUNCH) - ASCO Publications

JCO Resource Centers. Breast CancerNon–Small Cell Lung CancerRenal Cell ... Small Cell Lung Cancer: New Hope, New Challenges. Recommended ...

Liver Cancer Clinical Trials - NCI

Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for ...

ESMO Clinical Trials Tips and Tricks - OncologyPRO

New resources are added on a regular basis. Check for recent updates! Principles of Clinical Trials and Systemic Therapy. Resources from ESMO Congress 2016.

ClinicalTrials.gov: Home

A research study involving human volunteers (also called participants) that is intended to add to medical knowledge. There are two types of clinical studies: ...

Cancer Clinical Trials | Cancer Research Institute

... research and the growing opportunities to participate in new cancer clinical trials. ... Download cancer clinical trial resources from the National Cancer ...

Dr. Bruix on the Phase III RESORCE Trial in HCC - OncLive

... new first-line treatment option to patients.” In March 2020, the FDA ... https://www.fda.gov/drugs/resources-information-approved-drugs ...

Prostate Cancer Clinical Trials

Clinical trials bring life extending and curative new treatments to cancer patients.Use this tool to find clinical trials.